Psychological distress as a risk factor for death from cerebrovascular disease

Hamer, Mark; Kivimäki, Mika; Stamatakis, Emmanuel

doi:10.1503/cmaj.111719

Cited by 34 publications

(29 citation statements)

References 27 publications

(42 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Evidence from prospective cohort studies in humans that has emerged over the last several decades consistently demonstrates an association between various psychosocial risk factors and future risk of cardiovascular disease (CVD) in both initially healthy samples and cardiac patients (1)(2)(3)(4), with effect sizes that are comparable to conventional risk factors such as hypertension, obesity and smoking (5).…”

Section: Introductionmentioning

confidence: 99%

Psychosocial Stress and Cardiovascular Disease Risk

Hamer

2012

Psychosomatic Medicine

Self Cite

123

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Psychosocial Stress and Cardiovascular Disease Risk

Hamer

2012

Psychosomatic Medicine

Self Cite

123

View full text Add to dashboard Cite

“…Previous research has indicated that psychological conditions can influence a person's risk of cardiovascular diseases. 24,25 Hamer et al documented that psychological distress is connected with increased mortality from cerebrovascular disease. 25 One of the possible explanations for the lagging effect of margin trading may be due to regulation.…”

Section: Discussionmentioning

confidence: 99%

“…24,25 Hamer et al documented that psychological distress is connected with increased mortality from cerebrovascular disease. 25 One of the possible explanations for the lagging effect of margin trading may be due to regulation. In Taiwan, investors who receive a margin call do not need to sell off their stocks or add more cash to their margin account immediately; rather, they are forced to make this decision two business days after receiving the margin call.…”

Section: Discussionmentioning

confidence: 99%

Stroke: a Hidden Danger of Margin Trading in Stock Markets

et al. 2015

View full text Add to dashboard Cite

Using 10-year population data from 2000 through 2009 in Taiwan, this is the first paper to analyze the relationship between margin trading in stock markets and stroke hospitalizations. The results show that 3 and 6 days after an increase of margin trading in the Taiwan stock markets are associated with greater stoke hospitalizations. In general, a 1 % increase in total margin trading positions is associated with an increment of 2.5 in the total number of stroke hospitalizations, where the mean number of hospital admissions is 233 cases a day. We further examine the effects of margin trading by gender and age groups and find that the effects of margin trading are significant for males and those who are 45-74 years old only. In summary, buying stocks with money you do not have is quite risky, especially if the prices of those stocks fall past a certain level or if there is a sudden and severe drop in the stock market. There is also a hidden danger to one's health from margin trading. A person should be cautious before conducting margin trading, because while it can be quite profitable, danger always lurks just around the corner.

show abstract

“…I n a related CMAJ article, Hamer and colleagues 1 report results from the Health Survey for England showing an association between baseline psychological distress and subsequent increased risk of death due to cerebrovascular disease. Their results are in concordance with findings from previous observational studies and highlight the connection between psy chological and cardiovascular health.…”

mentioning

confidence: 99%

“…Cognitive behavioural therapy may provide additional benefits in conjunction with standard treatment. 10 In light of the findings by Hamer and colleagues, 1 we need further studies to test whether treatment aimed at alleviating psychological distress (e.g., pharmacological medications, cognitive behavioural therapy and lifestyle management) will reduce cardiovascular risk. A well-designed clinical trial may answer the question, but it will require a study of large sample size and sufficient long-term follow-up to test change in outcomes related to cardiovascular disease.…”

mentioning

confidence: 99%